Christopher K. Cox, Chief Product Officer of Meta Platforms, Inc. (NASDAQ:META), filed a Form 4 on September 11, 2026, disclosing the sale of 20,000 shares of Class A Common Stock on September 9, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Christopher K. Cox, Chief Product Officer of Meta Platforms, Inc.
  • Shares sold: 18,578 shares at a weighted average price of $650.2121 per share, and 1,422 shares at a weighted average price of $651.1496 per share, for a combined total of 20,000 shares disposed of on September 9, 2026.
  • Price ranges: The first block was sold at prices ranging from $650.00 to $650.93; the second block at prices ranging from $651.015 to $651.26 per share.
  • Trading plan: Both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Cox on May 19, 2026.
  • Remaining indirect ownership: Following the transactions, Cox holds 244,516 shares indirectly through The Christopher K. Cox Revocable Trust and 55,046 shares indirectly through The Cox-Vadakan Irrevocable Remainder Trust.
  • Ownership structure: The revocable trust shares are held of record by Christopher K. Cox as trustee; the irrevocable remainder trust shares are held by Christopher K. Cox and Visra Vichit-Vadakan as co-trustees.

Cox's Rule 10b5-1 Sales and Beneficial Ownership After the Transactions

According to the filing, Cox disposed of shares in two separate transactions on September 9, 2026. In the first transaction, 18,578 shares were sold at a weighted average price of $650.2121, with individual sale prices ranging from $650.00 to $650.93 per share. In the second transaction, 1,422 shares were sold at a weighted average price of $651.1496, with individual prices ranging from $651.015 to $651.26 per share. The filing notes that the holder undertakes to provide full information on the number of shares sold at each separate price within those ranges upon written request.

The filing states that both sales were made pursuant to a Rule 10b5-1 trading plan that Cox adopted on May 19, 2026. The Form 4 indicates the box was checked confirming the transactions were made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

All shares reported as beneficially owned following the transactions are held indirectly. The filing identifies 244,516 shares remaining in The Christopher K. Cox Revocable Trust and 55,046 shares held in The Cox-Vadakan Irrevocable Remainder Trust, for which Cox and Visra Vichit-Vadakan serve as co-trustees. No directly owned shares or derivative securities were reported in the filing. The Form 4 was signed by Erin Guldiken as attorney-in-fact for Christopher K. Cox and filed on September 11, 2026.

What Was Disclosed

The filing discloses the sale of 20,000 shares of Meta Platforms Class A Common Stock by Chief Product Officer Christopher K. Cox on September 9, 2026, under a pre-established 10b5-1 plan, with remaining indirect beneficial ownership of 299,562 shares across two trusts.